Uppsala

• An international study to evaluate the safety and effectiveness of enzalutamide plus leuprolide, enzalutamide alone, and leuprolide alone in … Ended recruitment
  2024-513521-23-00 5 2015-08-19 Prostate Cancer
• PREDIX HER2 - preoperative treatment of HER2 positive breast cancer Ended recruitment
  2023-508411-23-00 4 2014-11-12 Primary breast cancer
• A phase 3, randomised, double-blind, placebo-controlled, parallel-arm efficacy trial of Imatinib in acute ischaemic stroke Halted
  2023-506178-11-00 5 2025-11-11 Acute ischemic stroke
• A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study, to Assess Efficacy, Safety and Immunogenicity of JNJ-6404 … Halted
  2023-505096-68-00 4 2025-01-14 Preclinical Alzheimer’s Disease
• A phase 1, randomized, double-blind, single-center, placebo-controlled first-in-human trial to assess the safety, tolerability, pharmacokine … Halted
  2023-510371-55-00 1 2024-11-14 Complement-mediated diseases
• CAPSI - Cancer related major depression treated with a single dose of psilocybin - a multicenter randomized placebo controlled double blind … Halted
  2023-505532-35-00 4 2024-05-15 Malignant tumours ICD 10 C00 to C97
• A randomized, open-label, multicentric, two-arm pivotal trial of SonoCloud-9 combined with carboplatin (CBDCA) vs standard of care lomustine … Halted
  2023-505829-14-00 5 2023-12-22 First recurrence glioblastoma
• A randomized, three-period, single-dose crossover trial in healthy female volunteers to demonstrate bioequivalence of tafoxiparin following … Ended
  2025-521140-38-00 2 2026-02-11 Labor priming
• An open, single arm, single-center, Phase 1 trial investigating the effect of 7-days-repeated administration of linaprazan glurate on the ph … Ended
  2024-518194-34-00 3 2025-11-11 Helicobacter pylori infection, GERD
• A randomised, double-blind, placebo-controlled phase Ib trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of … Ended
  2025-522287-32-00 3 2025-10-22 Depression
• Treatment of normal pressure hydrocephalus with acetazolamide Ended
  2024-514828-16-00 4 2025-09-25 Normal pressure hydrocephalus
• A prospective, double-blinded, randomized, placebo-controlled phase 1/2a study to assess safety, tolerability, systemic exposure and prelimi … Ended
  2024-517920-21-00 9 2025-08-19 knee osteoarthritis
• A randomised, open-label, 5-period, cross-over trial to assess the pharmacokinetics and safety of 3 oral solid formulations of buloxibutid ( … Ended
  2025-520702-35-00 3 2025-05-14 Idiopahtic pulmonary fibrosis
• A PilOt dose-escalation trial with EMP16 in preparation for Phase III – the POEM trial Ended
  2024-520122-11-00 4 2025-05-07 Obesity
• A phase 1, open-label trial in healthy subjects and in subjects with diabetes investigating pharmacokinetics, tolerability, safety, and food … Ended
  2024-515078-28-00 3 2025-04-16 Diabetic Retinopathy
• A FIRST-IN-HUMAN PHASE I TRIAL OF OX118 IN HEALTHY VOLUNTEERS Ended
  2024-515378-28-00 1 2025-04-03 Immune system Diseases
• An open-label, prospective, randomised, cross-over trial to assess the pharmacokinetics of an amorphous formulation of sorafenib in mesoporo … Ended
  2024-514496-18-01 3 2025-01-30 Hepatocellular carcinoma, renal cell carcinoma and differentiated thyr
• An open-label, randomised, single-dose, three-way cross-over trial to assess the pharmacokinetics of NIC24-01 and NIC24-02 oromucosal pouche … Ended
  2024-514676-40-00 3 2024-12-12 Nicotine dependence
• Safety Trial, DSC vs. BAT in SR acute GvHD Ended
  2024-511768-97-01 4 2024-11-20 Graft vs Host Disease
• A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Letrozole Compared to Letrozole Alone in Postmenopausal Wom … Ended
  2024-512848-30-00 4 2024-11-12 HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE BREAST CANCER
• A Phase 2a, Randomised, Double-blind, Parallel and Placebo-controlled Trial Investigating Safety and Efficacy of LIB-01 in Treatment of Erec … Ended
  2024-515065-34-00 4 2024-11-07 Erectile dysfunction (ED)
• A multi-centre, randomised, single-blind Phase I/IIa study to evaluate the safety, tolerability and efficacy of a single topical dose of all … Ended
  2024-518757-42-00 9 2024-10-28 Difficult-to-heal venous leg ulcers
• A Study to Evaluate the Efficacy and Safety of TAK-861 for the Treatment of Narcolepsy with Cataplexy Ended
  2024-511998-30-00 5 2024-10-18 Narcolepsy with Cataplexy (Narcolepsy Type 1)
• An open-label, crossover trial in otherwise healthy volunteers with allergic rhinitis to evaluate the relative bioavailability and hemodynam … Ended
  2024-514037-38-00 3 2024-10-01 Anaphylaxis

Showing 265–288 of 349 trials